CSPIA
Cary Street Partners Investment Advisory’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
6,809
-92
| -1% | -$17.1K | 0.61% | 34 |
|
|
2025
Q1 | $1.45M | Buy |
6,901
+621
| +10% | +$130K | 0.83% | 25 |
|
|
2024
Q4 | $1.12M | Sell |
6,280
-123,590
| -95% | -$22M | 0.73% | 30 |
|
|
2024
Q3 | $25.6M | Buy |
129,870
+3,952
| +3% | +$780K | 0.95% | 16 |
|
|
2024
Q2 | $21.6M | Buy |
125,918
+3,822
| +3% | +$656K | 0.87% | 19 |
|
|
2024
Q1 | $22.2M | Buy |
122,096
+1,712
| +1% | +$312K | 0.94% | 16 |
|
|
2023
Q4 | $18.7M | Buy |
120,384
+1,930
| +2% | +$299K | 0.89% | 18 |
|
|
2023
Q3 | $17.7M | Buy |
118,454
+25,813
| +28% | +$3.85M | 0.95% | 16 |
|
|
2023
Q2 | $12.5M | Buy |
92,641
+1,539
| +2% | +$207K | 0.8% | 25 |
|
|
2023
Q1 | $14.5M | Sell |
91,102
-127
| -0.1% | -$20.2K | 1.04% | 13 |
|
|
2022
Q4 | $14.7M | Sell |
91,229
-2,091
| -2% | -$338K | 1.09% | 15 |
|
|
2022
Q3 | $12.5M | Buy |
93,320
+7,123
| +8% | +$956K | 1.03% | 22 |
|
|
2022
Q2 | $13.2M | Buy |
86,197
+70,250
| +441% | +$10.8M | 1.12% | 14 |
|
|
2022
Q1 | $2.59M | Sell |
15,947
-1,434
| -8% | -$232K | 0.71% | 38 |
|
|
2021
Q4 | $2.35M | Buy |
17,381
+4,131
| +31% | +$559K | 0.65% | 45 |
|
|
2021
Q3 | $1.43M | Sell |
13,250
-248
| -2% | -$26.7K | 0.47% | 67 |
|
|
2021
Q2 | $1.52M | Buy |
13,498
+5,710
| +73% | +$643K | 0.49% | 62 |
|
|
2021
Q1 | $843K | Sell |
7,788
-12,972
| -62% | -$1.4M | 0.35% | 73 |
|
|
2020
Q4 | $2.22M | Sell |
20,760
-47,184
| -69% | -$5.05M | 0.43% | 54 |
|
|
2020
Q3 | $5.95M | Buy |
67,944
+64,174
| +1,702% | +$5.62M | 1.26% | 12 |
|
|
2020
Q2 | $370K | Buy |
3,770
+411
| +12% | +$40.3K | 0.52% | 55 |
|
|
2020
Q1 | $255K | Buy |
3,359
+336
| +11% | +$25.5K | 0.6% | 48 |
|
|
2019
Q4 | $268K | Buy |
+3,023
| New | +$268K | 0.29% | 95 |
|
|
2018
Q4 | $279K | Buy |
+3,033
| New | +$279K | 0.27% | 70 |
|